Effects of TAK gene silencing on the expressions of IL-6 and IL-8 induced by TNF-α in fibroblast-like synoviocytes

doi:10.12047/j.cjap.5494.2017.113

CJAP ›› 2017, Vol. 33 ›› Issue (5): 471-475.doi: 10.12047/j.cjap.5494.2017.113

Previous Articles Next Articles

Effects of TAK gene silencing on the expressions of IL-6 and IL-8 induced by TNF-α in fibroblast-like synoviocytes

MO Xuan-rong¹, XIE Jiang-wen², LV Guo-ju², KE Yu-ping¹, LUO Xin-jing¹

1. Department of Basic Medical Sciences, School of Medicine of Taizhou University, Taizhou 318000;
2. Department of Cardiology, Yingzhou District Second people's Hospital, Ningbo 315000, China

Received:2016-09-09 Revised:2017-05-15 Online:2017-09-28 Published:2018-06-19
Supported by:
国家自然科学基金面上项目（81373139）；浙江省自然科学基金（LY16H100001）；浙江省医药卫生科研项目（2015KYA206）

Abstract

Abstract: Objective: To investigate the effects of silencing transforming growth factor-β activating kinase 1 (TAK1)on the expressions of IL-6 and IL-8 induced by TNF-α in fibroblast-like synoviocytes, and to explore the role of TAK1 in rheumatoid arthritis (RA).Methods: The synthesized TAK1 siRNA and scrambled siRNA (ScRNA) were transferred into cultured RA fibroblast-like synoviocyte line MH7A by lipofectamine. The expressions of the pro-inflammatory mediator IL-6 and IL-8 and the levels of phospho-P38(p-P38), phospho-C-Jun NH2-terminal kinase(p-JNK), phospho-extracellular signal-regulated kinase(p-ERK), phospho-p65(p-p65) and nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha(IκBa) were examined.Results: Silencing of TAK was demonstrated in synoviocytes transfected by TAK siRNA. TAK1 silencing markedly attenuated the expression of IL-6 and IL-8 in the presence of TNF-α. TAK1 silencing inhibited the activation of p38 and JNK MAPK. TAK1 silencing also inhibited activation of nuclear factor-κB (NF-κB).Conclusion: TAK1 silencing attenuated the expression of IL-6 and IL-8 in synoviocytes induced by TNF-α via inhibiting the activation of p38, JNK MAPK and NF-κB.

Key words: rheumatoid arthritis, synoviocytes, inflammatory mediators, TAK1

MO Xuan-rong, XIE Jiang-wen, LV Guo-ju, KE Yu-ping, LUO Xin-jing. Effects of TAK gene silencing on the expressions of IL-6 and IL-8 induced by TNF-α in fibroblast-like synoviocytes[J]. CJAP, 2017, 33(5): 471-475.

References

[1] Sato S, Sanjo H, Takeda K, et al. Essential function for the kinase TAK1 in innate and adaptive immune responses[J]. Nat Immunol, 2005, 6(11):1087-1095.
[2] Meyer LH, Pap T. MAPK signalling in rheumatoid joint destruction:can we unravel the puzzle[J]. Arthritis Res Ther, 2005, 7(5):177-178.
[3] Neff L, Zeisel M, Sibilia J, et al. NF-kappaB and the MAP kinases/A P-1 pat hways are both involved in interleukin-6 and interleukin-8 expression in fibro bl ast-like synoviocytes stimulated by protein I/Ⅱ, a modulin from oral streptoco cci[J]. Cell Microbiol, 2001, 3(10):703-712.
[4] Hammaker D, Sweeney S, Firestein GS. Signal transduction networks in rheu matoid arthritis[J]. Ann Rheum Dis, 2003, 62(Suppl 2):ii86-89.
[5] Delaney JR, Mlodzik M. TGF-beta activated kinase-1:new insights into the diverse roles of TAK1 in development and immunity[J]. Cell Cycle, 2006, 5(24):2852-2855.
[6] Geurts J, van den Brand BT, Wolf A, et al. Toll-like receptor 4 sig nalling is spec ifically TGF-beta-activated kinase 1 independent in synovial fibroblasts[J]. Rheumatology (Oxford), 2011, 50(7):1216-1225.
[7] Hammaker DR, Boyle DL, Chabaud-Riou M, et al. Regulation of c-Jun N-termin al kinase by MEKK-2 and mitogen-activated protein kinase kinase kinases in rhe umatoid arthritis[J]. J Immunol, 2004, 172(3):1612-1618.
[8] Mor A, Abramson SB, Pillinger MH. The fibroblast-like synovial cell in rheumatoid arthritis:a key player in inflammation and joint destruction[J]. Cl in Immunol, 2005,115(2):118-128.
[9] Georganas C, Liu H, Perlman H, et al. Regulation of IL-6 and I L-8 expressi on in rheumatoid arthritis synovial fibroblasts:the dominant role for NF-kappa B but not C/EBP beta or c-Jun[J]. J Immunol, 2000, 165(12):7199-7206.
[10] Matsumoto T, Tsurumoto T, Shindo H. Interleukin-6 levels in synovial fluids of patients with rheumatoid arthritis correlated with the infiltration of infl ammatory cells in synovial membrane[J]. Rheumatol Int, 2006, 26(12):1096-1100.
[11] Hennigan S, Kavanaugh A. Interleukin-6 inhibitors in the treatment of rhe umatoid arthritis[J]. Ther Clin Risk Manag, 2008, 4(4):767-775.
[12] Choy E. Inhibiting interleukin-6 in rheumatoid arthritis[J]. Curr Rheumatol Rep, 2008, 10(5):413-417.
[13] Nanki T, Nagasaka K, Hayashida K, et al. Chemokines regulate IL-6 and IL-8 production by fibroblast-like synoviocytes from patients with rheumatoid arthr itis[J]. J Immunol, 2001, 167(9):5381-5385.
[14] Klatt AR, Klinger G, Neumuller O, et al. TAK1 downregulation reduces IL-1b eta induced expression of MMP13, MMP1 and TNF-alpha[J]. Biomed Pharmacother, 2006, 60(2):55-61.
[15] 罗心静, 莫选荣, 周玲玲. Hsp72对类风湿关节炎滑膜细胞IL-6、IL-8表达及NF-kB活化的影响[J]. 中国应用生理学杂志, 2012, 28(4):336-339.
[16] 张国霞, 周爱玲, 张贵萍, 等. 大鼠海马神经元TLR4介导的MyD88依赖途径在神经炎症中的作用[J]. 中国应用生理学杂志, 2013, 29(1):42-46.

Effects of TAK gene silencing on the expressions of IL-6 and IL-8 induced by TNF-α in fibroblast-like synoviocytes

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 3

Recommended Articles

Metrics

Comments

[1]	. [J]. CJAP, 2018, 34(1): 13-15.
[2]	XIANG Bing-qian, HE Jin-bo, GAO Hui, LUO Zi-yin, DAI Yong-yue, WANG Wan-tie. Effects of Dexmedetomidine on the levels of proinflammatory mediators IL-1βand TNF-α in pulmonary ischemia/reperfusion injury rats and the mechanisms [J]. CJAP, 2017, 33(5): 415-419.
[3]	LIU Cai-li, WANG Ying-ying. Effects of TNF-alpha/NF-kappa B signaling pathway on etanercept alleviating rheumatoid arthritis [J]. CJAP, 2017, 33(4): 373-376.